These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 31985852)

  • 1. Interlaboratory analysis of teicoplanin plasma concentration assays among Chinese laboratories.
    Wang XX; Jin PF; Li PM; Xu S; Kong XD; Qin W; Chen WQ; Qin WJ; Zhang XL
    J Clin Pharm Ther; 2020 Oct; 45(5):983-990. PubMed ID: 31985852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measurement of Teicoplanin Concentration With Liquid Chromatography-Tandem Mass Spectrometry Method Demonstrates the Usefulness of Therapeutic Drug Monitoring in Hematologic Patient Populations.
    Chae H; Lee JJ; Cha K; Her SH; Kim HY; Han E; Kim M; Kim Y; Cho SY; Lee DG
    Ther Drug Monit; 2018 Jun; 40(3):330-336. PubMed ID: 29746433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic drug monitoring of teicoplanin using an LC-MS/MS method: Analysis of 421 measurements in a naturalistic clinical setting.
    Jung J; Lee K; Oh J; Choi R; Woo HI; Park HD; Kang CI; Kim YJ; Lee SY
    J Pharm Biomed Anal; 2019 Apr; 167():161-165. PubMed ID: 30776754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and Validation of a High-Performance Liquid Chromatography With Ultraviolet Detection Method to Facilitate Therapeutic Monitoring of Teicoplanin Using Dried Blood Spots.
    Ramadan O; Opitz P; Hempel G
    Ther Drug Monit; 2024 Oct; 46(5):627-633. PubMed ID: 38917389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The quality of clinical serum teicoplanin assays: an experimental European EQA distribution.
    White LO; McMullin C; Davis AJ; MacGowan AP; Harding I; Reeves DS
    J Antimicrob Chemother; 1996 Oct; 38(4):701-6. PubMed ID: 8937964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An assessment of teicoplanin use and monitoring serum levels in a Chinese teaching hospital.
    Dong YL; Dong HY; Hu SS; Wang X; Wei YX; Wang MY; Dong WH; Yao HP; You HS; Xing JF
    Int J Clin Pharmacol Ther; 2011 Jan; 49(1):14-22. PubMed ID: 21176720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors on trough teicoplanin levels, associations between levels, efficacy and safety in patients with gram-positive infections.
    Wang T; Li N; Hu S; Xie J; Lei J; Wang Y; Zheng X; Xing J; Dong Y
    Int J Clin Pharmacol Ther; 2015 May; 53(5):356-62. PubMed ID: 25828639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrated identification-quantification (ID-Quant) workflow utilizing UPLC-QTOF-MS for the therapeutic drug monitoring of multi-component antibiotics without pure standards: Validation using teicoplanin.
    Ma X; Zou Y; Zhong J; Yu S; Qiu L
    J Chromatogr B Analyt Technol Biomed Life Sci; 2024 Jun; 1240():124132. PubMed ID: 38714089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An ultra-high pressure liquid chromatography-tandem mass spectrometry method for the quantification of teicoplanin in plasma of neonates.
    Begou O; Kontou A; Raikos N; Sarafidis K; Roilides E; Papadoyannis IN; Gika HG
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Mar; 1047():215-222. PubMed ID: 26896312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simultaneous quantification of antimicrobial agents for multidrug-resistant bacterial infections in human plasma by ultra-high-pressure liquid chromatography-tandem mass spectrometry.
    Tsai IL; Sun HY; Chen GY; Lin SW; Kuo CH
    Talanta; 2013 Nov; 116():593-603. PubMed ID: 24148450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluating the optimal dose of teicoplanin with therapeutic drug monitoring: not too high for adverse event, not too low for treatment efficacy.
    Kim SH; Kang CI; Huh K; Cho SY; Chung DR; Lee SY; Kim YJ; Peck KR
    Eur J Clin Microbiol Infect Dis; 2019 Nov; 38(11):2113-2120. PubMed ID: 31372903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of teicoplanin trough concentration target and appropriate total dose during the first 3 days: a retrospective study in patients with MRSA infections.
    Matsumoto K; Kanazawa N; Ikawa K; Fukamizu T; Shigemi A; Yaji K; Shimodozono Y; Morikawa N; Takeda Y; Yamada K
    J Infect Chemother; 2010 Jun; 16(3):193-9. PubMed ID: 20195882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A simplified chart for determining the initial loading dose of teicoplanin in critically ill patients.
    Yoshida S; Suzuki A; Ohmori T; Niwa T; Okada H; Suzuki K; Kobayashi R; Doi T; Kitaichi K; Matsuura K; Murakami N; Ogura S; Itoh Y
    Pharmazie; 2017 Jan; 72(1):53-57. PubMed ID: 29441898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic drug monitoring status of four common antibiotics: vancomycin, meropenem, linezolid and teicoplanin.
    Zhou W; Deng Y; Liu X; Liu Z; Huang C; Miao L; Zhang C
    Scand J Clin Lab Invest; 2022; 82(7-8):556-562. PubMed ID: 36300737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of a Reversed-Phase Ultra-High-Performance Liquid Chromatographic Method With Photodiode Array Detection for the Determination of Voriconazole in Human Serum and Its Application to Therapeutic Drug Monitoring.
    Bressán IG; Mendez ML; Gimenez MI
    Ther Drug Monit; 2018 Apr; 40(2):276-283. PubMed ID: 29432386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased teicoplanin doses are associated with improved serum levels but not drug toxicity.
    Matthews PC; Chue AL; Wyllie D; Barnett A; Isinkaye T; Jefferies L; Lovering A; Scarborough M
    J Infect; 2014 Jan; 68(1):43-9. PubMed ID: 24012820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loading dose required to achieve rapid therapeutic teicoplanin trough plasma concentration in patients with multidrug-resistant gram-positive infections.
    Wang JT; Liao HI; Wu Lin FL; Chang SC
    Basic Clin Pharmacol Toxicol; 2012 May; 110(5):416-20. PubMed ID: 22309355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use and therapeutic drug monitoring of teicoplanin in the UK.
    Darley ES; MacGowan AP
    Clin Microbiol Infect; 2004 Jan; 10(1):62-9. PubMed ID: 14706088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel reversed-phase high-performance liquid chromatographic assay for the simultaneous determination of imipenem and meropenem in human plasma and its application in TDM.
    Zou L; Meng F; Hu L; Huang Q; Liu M; Yin T
    J Pharm Biomed Anal; 2019 May; 169():142-150. PubMed ID: 30861406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LC-MS/MS method for simultaneous determination of linezolid, meropenem, piperacillin and teicoplanin in human plasma samples.
    Ferrari D; Ripa M; Premaschi S; Banfi G; Castagna A; Locatelli M
    J Pharm Biomed Anal; 2019 May; 169():11-18. PubMed ID: 30826487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.